For help on how to get the results you want, see our search tips.
10100 results
-
List item
Human medicine European public assessment report (EPAR): Shingrix (updated)
Recombinant varicella zoster virus glycoprotein E, Herpes Zoster
Date of authorisation: 21/03/2018,
, Revision: 6, Authorised, Last updated: 30/04/2021
-
List item
Human medicine European public assessment report (EPAR): Rivastigmine 1 A Pharma (updated)
rivastigmine, Alzheimer Disease, Dementia, Parkinson Disease
Date of authorisation: 11/12/2009, Revision: 10, Authorised, Last updated: 30/04/2021 -
List item
Human medicine European public assessment report (EPAR): Dacogen (updated)
Decitabine, Leukemia, Myeloid
Date of authorisation: 20/09/2012,
, Revision: 14, Authorised, Last updated: 30/04/2021
-
List item
Human medicine European public assessment report (EPAR): Repatha (updated)
Evolocumab, Dyslipidemias, Hypercholesterolemia
Date of authorisation: 17/07/2015, Revision: 18, Authorised, Last updated: 29/04/2021 -
List item
Human medicine European public assessment report (EPAR): Nivestim (updated)
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 07/06/2010,
, Revision: 23, Authorised, Last updated: 29/04/2021
-
List item
Veterinary medicine European public assessment report (EPAR): Dexdomitor (updated)
dexmedetomidine hydrochloride, Dogs, Cats
Date of authorisation: 30/08/2002, Revision: 20, Authorised, Last updated: 29/04/2021 -
List item
Human medicine European public assessment report (EPAR): Xtandi (updated)
enzalutamide, Prostatic Neoplasms
Date of authorisation: 21/06/2013,
Date of refusal: 26/04/2013, Revision: 17, Authorised, Last updated: 29/04/2021 -
List item
Human medicine European public assessment report (EPAR): Nemdatine (updated)
memantine, Alzheimer Disease
Date of authorisation: 22/04/2013,
Date of refusal: 22/02/2013,
, Revision: 10, Authorised, Last updated: 29/04/2021
-
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
irinotecan anhydrous free-base, Pancreatic Neoplasms
Date of authorisation: 14/10/2016,, Revision: 8, Authorised, Last updated: 29/04/2021
-
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,, 
, Revision: 6, Authorised, Last updated: 29/04/2021
-
List item
Human medicine European public assessment report (EPAR): Ocrevus (updated)
ocrelizumab, Multiple Sclerosis
Date of authorisation: 08/01/2018,, Revision: 11, Authorised, Last updated: 29/04/2021
-
List item
Human medicine European public assessment report (EPAR): Victoza (updated)
liraglutide, Diabetes Mellitus, Type 2
Date of authorisation: 30/06/2009, Revision: 22, Authorised, Last updated: 29/04/2021 -
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Pembrolizumab, Melanoma, Hodgkin Disease, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urologic Neoplasms, Squamous Cell Carcinoma of Head and Neck
Date of authorisation: 17/07/2015,, Revision: 33, Authorised, Last updated: 29/04/2021
-
List item
Human medicine European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan (updated)
emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 16/12/2016,, Revision: 8, Authorised, Last updated: 29/04/2021
-
List item
Human medicine European public assessment report (EPAR): Vipdomet (updated)
alogliptin benzoate, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 18/09/2013, Revision: 8, Authorised, Last updated: 29/04/2021 -
List item
Human medicine European public assessment report (EPAR): Lorviqua (updated)
Lorlatinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 06/05/2019,, , Revision: 5, Authorised, Last updated: 29/04/2021
-
List item
Human medicine European public assessment report (EPAR): Lysodren (updated)
Mitotane, Adrenal Cortex Neoplasms
Date of authorisation: 28/04/2004, Revision: 16, Authorised, Last updated: 29/04/2021 -
List item
Human medicine European public assessment report (EPAR): Blincyto (updated)
blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 23/11/2015,, , Revision: 12, Authorised, Last updated: 29/04/2021
-
List item
Human medicine European public assessment report (EPAR): Skilarence (updated)
dimethyl fumarate, Psoriasis
Date of authorisation: 23/06/2017, Revision: 8, Authorised, Last updated: 28/04/2021 -
List item
Human medicine European public assessment report (EPAR): Omnitrope (updated)
somatropin, Turner Syndrome, Prader-Willi Syndrome, Dwarfism, Pituitary
Date of authorisation: 12/04/2006,, Revision: 18, Authorised, Last updated: 28/04/2021
-
List item
Human medicine European public assessment report (EPAR): Evista (updated)
raloxifene hydrochloride, Osteoporosis, Postmenopausal
Date of authorisation: 05/08/1998, Revision: 25, Authorised, Last updated: 28/04/2021 -
List item
Human medicine European public assessment report (EPAR): Myozyme (updated)
alglucosidase alfa, Glycogen Storage Disease Type II
Date of authorisation: 28/03/2006, Revision: 18, Authorised, Last updated: 28/04/2021 -
List item
Human medicine European public assessment report (EPAR): Trulicity (updated)
dulaglutide, Diabetes Mellitus, Type 2
Date of authorisation: 21/11/2014, Revision: 14, Authorised, Last updated: 28/04/2021 -
List item
Human medicine European public assessment report (EPAR): Elonva (updated)
corifollitropin alfa, Reproductive Techniques, Assisted, Ovulation Induction
Date of authorisation: 25/01/2010, Revision: 18, Authorised, Last updated: 28/04/2021 -
List item
Human medicine European public assessment report (EPAR): HyQvia (updated)
Human normal immunoglobulin, Immunologic Deficiency Syndromes
Date of authorisation: 16/05/2013,, Revision: 16, Authorised, Last updated: 28/04/2021